Clinical trialNCT03350269TerminatedInterventional

Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates

SponsorArbor Research Collaborative for HealthEnrollment1,310Kidney FailureRenal FailureSurgery

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study is designed as a randomized controlled trial. The investigators hypothesize that kidney transplant recipient candidates whose donors are offered reimbursement of lost wages (treatment arm) will have a higher probability of receiving a living donor kidney transplant than those randomized to no offer of lost wage reimbursement (control arm). The study expects to demonstrate incremental living donor kidney transplants by assisting individuals who wish to be living organ donors but would be otherwise unable to do so due to the obligatory forfeit of income during the evaluation, donation surgery, and post-operative recuperation periods.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Akinlolu O. Ojo, MD, PhD, MBA
University of Arizona Health Sciences
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Amit K. Mathur, MD
Mayo Clinic
Principal Investigator
clinicaltrials.gov ↗
Judd Kessler, PhD
Wharton School, University of Pennsylvania
Principal Investigator
clinicaltrials.gov ↗
Kimberly A. Gifford, MBA
American Society of Transplant Surgeons
Principal Investigator
clinicaltrials.gov ↗
Robert M. Merion, MD, FACS
Arbor Research Collaborative for Health
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucla Kidney and Pancreas Transplant Program in Collaboration With the Transplant Research and Education Center (trec)
Los Angeles, California, United States
University of Colorado
Denver, Colorado, United States
Michigan Medicine - University of Michigan
Ann Arbor, Michigan, United States
University of Minnesota
Minneapolis, Minnesota, United States
Mt. Sinai Medical Center
New York, New York, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Nov 2017
Primary completion: 17 Jun 2020
Completion: 20 Oct 2020
Last update posted: 3 Jan 2022
Registered enrollment: 1,310
Registry id: NCT03350269

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.